Organization

Ache Laboratorios Farmaceuticos

1 clinical trial

Clinical trial

Phase IV, National, Unicentric, Comparative, Double-Blind, Randomized, Non- Inferiority Clinical Trial to Evaluate the Efficacy and Safety of DNN.22.17.036 Compared to 10573048700 in the Treatment of Androgenetic Alopecia

Status: Not yet recruiting, Estimated PCD: 2025-05-01